Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Lagis Enterprise CoROCO:6730 91 PE Ratio without NRI is 17.77 as of Jul. 17, 2026, which is 71% below its 10-year median of 61.37. GuruFocus rates ROCO:6730 with a GF Score™ of 91/100 and a GF Value™ of NT$43.10 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 451 Medical Devices & Instruments companies, Lagis Enterprise Co ranks better than 65.63% on this metric.
The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. As of today (2026-07-17), Lagis Enterprise Co's share price is NT$37.50.
Lagis Enterprise Co's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was NT$2.11. Therefore, Lagis Enterprise Co's PE Ratio without NRI for today is 17.77.
During the past 10 years, Lagis Enterprise Co's highest PE Ratio without NRI was 112.20. The lowest was 16.52. And the median was 61.37.
Lagis Enterprise Co's EPS (Basic) for the
three
months ended in Dec. 2025 was NT$0.48.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$2.14.
Lagis Enterprise Co (ROCO:6730) PE Ratio without NRI Explanation
The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.
In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.
If a company loses money, the PE Ratio becomes meaningless.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.
Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.
Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.
Lagis Enterprise Co PE Ratio without NRI Related Terms
Lagis Enterprise Co PE Ratio without NRI Historical Data
* Premium members only.
The historical data trend for Lagis Enterprise Co's PE Ratio without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6730 vs ISRG, BDX, MDLN: PE Ratio without NRI Comparison
For the Medical Instruments & Supplies subindustry, Lagis Enterprise Co's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lagis Enterprise Co PE Ratio without NRI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Lagis Enterprise Co's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Lagis Enterprise Co's PE Ratio without NRI falls into.
Lagis Enterprise Co PE Ratio without NRI Calculation
The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. Regular PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than regular PE Ratio.
Lagis Enterprise Co's Share Price of today is NT$37.50.
Lagis Enterprise Co's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$2.11.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.
In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.
In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months.
For Forward PE Ratio, the earnings are the expected earnings for the next twelve months.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.
Lagis Enterprise Co (ROCO:6730) has a PE Ratio without NRI of 17.77 as of Jul. 17, 2026. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Lagis Enterprise Co and its competitors. This is 71% below median its historical median of 61.37. Over the past decade, Lagis Enterprise Co's PE Ratio without NRI has ranged from 16.52 to 112.20. According to the industry distribution chart, Lagis Enterprise Co ranks #155 out of 451 companies in the Medical Devices & Instruments industry, placing it in the top 34.4%.
Is Lagis Enterprise Co's PE Ratio without NRI too high?
Lagis Enterprise Co's current PE Ratio without NRI of 17.77 is 71% below median its 10-year median of 61.37. Over the past 10 years, this metric has ranged from a low of 16.52 to a high of 112.20. The Medical Devices & Instruments industry median PE Ratio without NRI is 23.77. Lagis Enterprise Co's value of 17.77 is 25.2% below this industry median. Based on the distribution chart, Lagis Enterprise Co ranks #155 out of 451 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Lagis Enterprise Co has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lagis Enterprise Co's PE Ratio without NRI compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Lagis Enterprise Co ranks #155 out of 451 companies for PE Ratio without NRI. This puts Lagis Enterprise Co in the upper half of its industry. The industry median PE Ratio without NRI is 23.77. Lagis Enterprise Co's value of 17.77 is 25.2% below this benchmark. Historically, Lagis Enterprise Co's own PE Ratio without NRI has ranged from 16.52 to 112.20 over the past decade. While the company's 10-year median is 61.37 vs. the industry median of 23.77, Lagis Enterprise Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio without NRI for a Medical Devices & Instruments company?
The median PE Ratio without NRI among Medical Devices & Instruments companies is 23.77, based on 451 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio without NRI significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lagis Enterprise Co's current PE Ratio without NRI of 17.77 is 25.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio without NRI mean?
A high PE Ratio without NRI can signal that a stock is expensive relative to its fundamentals. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Lagis Enterprise Co and its competitors. For the Medical Devices & Instruments industry, the median PE Ratio without NRI is 23.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lagis Enterprise Co's current PE Ratio without NRI is 17.77, which is 71% below median its own 10-year median of 61.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lagis Enterprise Co stock overvalued right now?
Based on GuruFocus' analysis, Lagis Enterprise Co (ROCO:6730) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$43.10, compared to a current price of NT$37.50 — trading 13% below its estimated fair value. The current PE Ratio without NRI is 17.77, which is 71% below median its 10-year median of 61.37 and 25.2% below the Medical Devices & Instruments industry median of 23.77. Lagis Enterprise Co's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio without NRI calculated?
PE Ratio without NRI is calculated from a company's financial statements. For Lagis Enterprise Co (ROCO:6730), the current PE Ratio without NRI is 17.77 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lagis Enterprise Co (ROCO:6730) Overvalued in 2026?
Based on GuruFocus' analysis, Lagis Enterprise Co stock appears to be undervalued.
The current stock price of NT$37.50 is trading 13% below its estimated GF Value™ of NT$43.10.
GuruFocus considers Lagis Enterprise Co to be Modestly Undervalued.
Key valuation signals for ROCO:6730:
PE Ratio without NRI: 17.77 (71% below median its 10-year median of 61.37)
GF Value™: NT$43.10 vs. price of NT$37.50 (13% below fair value)
Industry Position: 25.2% below the Medical Devices & Instruments median (#155 of 451)
No single metric tells the full story. See the ROCO:6730 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lagis Enterprise Co Ltd is a medical device development company that designs, patents, and markets medical devices for the laparoscopic and endoscopic surgical markets. Its product portfolio includes Access, Endo Devices, Specimen Retrieval products, Suction Irrigation systems, Training systems, and accessories.
91GF Score
Get the complete analysis for ROCO:6730
PE Ratio without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6730 has been successfully added to your 
